Paul Tudor Jones Boosts IREN Stake by 57 in Bet on AI Infrastructure Buildout Wingstop Stock Slides 12 After Quarterly Profit Misses Estimates Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project The Geopolitical Race for NextGeneration Computing Militaries Turn to Experimental Tech Beyond AI Telangana Cabinet Approves New Life Sciences Policy 202630 with RD Incentives Meta Settles Key Social Media Addiction Lawsuit Potentially Affecting Over 1200 Similar Claims NRG Q1 2026 Earnings EPS Misses Expectations Amid Mixed Performance BWLP Q4 2025 Earnings EPS Beats Estimates Stock Slips on Market Sentiment SYRE Q1 2026 Earnings EPS Miss Amidst No Revenue Focus on Pipeline Progress SPMA Q1 2026 Earnings Preferred Shares Dip on EPS Miss But Stock Edges Higher VSEC Q1 2026 Earnings Strong EPS Beat of 278 Masks Modest Stock Decline STRK Q1 2026 Earnings Preferred Stock Reports Deep EPS Shortfall as Revenue Remains Undisclosed Sabra Health Care REIT SBRA Slips 106 Support and Sector Headwinds in Focus Erayak Power Solution Group Inc RAYA Rises 16 as Stock Holds Above Key Support Nuveen California Municipal Value Fund NCA Edges Higher as Bond Market Stabilizes Douglas Elliman DOUG Dips Slightly Holds Above Key Support Amid Housing Market Uncertainty Lionheart Holdings Warrant CUBWW Surges 27 as Price Tests Key Resistance VolitionRx Named Among TopRated Penny Stocks as Veterinary Assay Milestone Nears SPG Q1 2026 Earnings Slight EPS Miss Amid Stable Retail Fundamentals Gildan Activewear GIL Holds Steady Near 58 as Support and Resistance Levels Come into Focus HCAT Q1 2026 Earnings Health Catalyst Posts EPS Beat Revenue Details Not Disclosed ExlService Holdings Inc EXLS Q1 2026 Earnings EPS Beats Estimates as Stock Edges Higher AIRO Q4 2025 Earnings Significant EPS Miss Beyond Expectations Stock Rises Banc of California Inc BANC Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Operating Performance AEMD Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares Modestly KBR Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher GLMD Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges